Zentalis Pharmaceuticals (ZNTL) Receivables - Accured (2020 - 2026)
Zentalis Pharmaceuticals (ZNTL) posted quarterly Receivables - Accured of $2.1 million for Q1 2026, down 23.27% year-over-year from $2.7 million in Q1 2025, and up 8.97% quarter-over-quarter from $1.9 million in Q4 2025.
Zentalis Pharmaceuticals (ZNTL) Receivables - Accured (2020 - 2026) Analysis & Trends
Zentalis Pharmaceuticals' Receivables - Accured history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Receivables - Accured fell 23.27% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 23.27% YoY), while the FY2025 annual figure was $1.9 million, down 34.49% from the prior year.
- Receivables - Accured for Q1 2026 stood at $2.1 million, up from $1.9 million in the prior quarter.
- The five-year high for Receivables - Accured was $3.3 million in Q4 2023, with the low at $266000.0 in Q1 2022.
- The 5-year median for Receivables - Accured is $2.1 million (2026), against an average of $1.9 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Accured jumped 719.48% in 2024, then slumped 34.83% in 2025.
- Zentalis Pharmaceuticals' Receivables - Accured stood at $508000.0 in 2022, then jumped by 556.89% to $3.3 million in 2023, then slipped by 11.81% to $2.9 million in 2024, then plunged by 34.49% to $1.9 million in 2025, then increased by 8.97% to $2.1 million in 2026.
- Business Quant data shows ZNTL's Receivables - Accured at $2.1 million in Q1 2026, $1.9 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acc. Int. Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Zentalis Pharmaceuticals | 255.14 Mn | 255.14 Mn | - | 1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.72 Mn |
| Jun 30, 2026 | 1.72 Mn |
| Mar 31, 2026 | 2.10 Mn |
| Mar 31, 2026 | 2.10 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 2.15 Mn |
| Sep 30, 2025 | 2.15 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Dec 31, 2024 | 2.94 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 3.28 Mn |
| Jun 30, 2024 | 3.28 Mn |
| Mar 31, 2024 | 3.16 Mn |
| Mar 31, 2024 | 3.16 Mn |